Prescription Drug User Fee Act reauthorization.
Biosimilar products.
H.R. 5651, Food and Drug Administration Reform Act of 2012.
S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Medicare Part B reimbursement and coverage of dialysis products. Prescription Drug User Fee Act reauthorization.
H.R. 5651, Food and Drug Administration Reform Act of 2012.
S. 3187, Food and Drug Administration Safety and Innovation Act.
H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
H.R. 6433, FDA User Fee Corrections Act of 2012. International trade issues. Economic policy.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations TRD - Trade (domestic/foreign) ECN - Economics/Economic Development
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
SHARON COHEN OSCAR RAMIREZ ANTHONY PODESTA SHARON COHEN SHARON COHEN OSCAR RAMIREZ ANTHONY PODESTA ANTHONY PODESTA ISRAEL S KLEIN